Atropine is a non-selective anticholinergic drug, mainly acting on muscarinic receptors (M receptors), used to relieve smooth muscle spasm, and also used to inhibit glandular secretion, relieve the inhibitory effect of vagus nerve on the heart and relieve organic Phosphate poisoning, etc.
This report contains market size and forecasts of Atropine Eye Drops in global, including the following market information:
Global Atropine Eye Drops Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Atropine Eye Drops Market Sales, 2017-2022, 2023-2028, (litre)
Global top five Atropine Eye Drops companies in 2021 (%)
The global Atropine Eye Drops market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Concentration: 0.0005 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Atropine Eye Drops include Xingqi Eye Drops, Tache Pharmacy, Japanese Towering, Eyenovia, Singapore National Eye Centre, Aier Eye Hospital Group and Aseptic Innovative Medicine, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Atropine Eye Drops manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Atropine Eye Drops Market, by Concentration, 2017-2022, 2023-2028 ($ Millions) & (litre)
Global Atropine Eye Drops Market Segment Percentages, by Concentration, 2021 (%)
Concentration: 0.0005
Concentration: 0.0001
Global Atropine Eye Drops Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (litre)
Global Atropine Eye Drops Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Atropine Eye Drops Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (litre)
Global Atropine Eye Drops Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Atropine Eye Drops revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Atropine Eye Drops revenues share in global market, 2021 (%)
Key companies Atropine Eye Drops sales in global market, 2017-2022 (Estimated), (litre)
Key companies Atropine Eye Drops sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Xingqi Eye Drops
Tache Pharmacy
Japanese Towering
Eyenovia
Singapore National Eye Centre
Aier Eye Hospital Group
Aseptic Innovative Medicine